Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

The Role of Ischemia Modified Albumin in Patients With COVID-19

  • Read more about The Role of Ischemia Modified Albumin in Patients With COVID-19

Postural Changes and Severe COVID-19

  • Read more about Postural Changes and Severe COVID-19

Using a Community-level Just-in-Time Adaptive Intervention to Address COVID-19 Testing Disparities

  • Read more about Using a Community-level Just-in-Time Adaptive Intervention to Address COVID-19 Testing Disparities

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

  • Read more about A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

  • Read more about Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

Neuro-inflammation and Post-infectious Fatigue in Individuals With and Without COVID-19

  • Read more about Neuro-inflammation and Post-infectious Fatigue in Individuals With and Without COVID-19

Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

  • Read more about Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

Study Design of the Diacerein in Patients With Covid-19

  • Read more about Study Design of the Diacerein in Patients With Covid-19

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

  • Read more about A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

  • Read more about A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Current page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA